Pharma & Biotech

Danish pharmaceutical leader Novo Nordisk is confronting a severe market downturn as major investors rapidly divest their holdings. The company's...

Redcare Pharmacy is making a strategic leadership move by appointing an Amazon finance veteran as its new Chief Financial Officer....

The Danish pharmaceutical firm Novo Nordisk, which held the title of Europe's most valuable corporation just a year ago, is...

Despite being mired in a significant downturn, Redcare Pharmacy is attracting attention from company insiders. A notable transaction has occurred...

UnitedHealth Group has made a strategic addition to its board of directors, bringing in former U.S. Food and Drug Administration...

Financial analysts are expressing growing enthusiasm for Eli Lilly's stock, with multiple firms raising their price projections as the pharmaceutical...

The independent existence of CureVac could soon be a chapter in corporate history. On November 25, shareholders will convene in...

Intellia Therapeutics captured significant market attention on November 16 when the biotechnology firm unveiled groundbreaking clinical trial data for its...

Halozyme Therapeutics is riding a wave of positive developments, with two significant announcements providing substantial momentum for the biotechnology firm....

A biotech firm suddenly flush with cash and developing a revolutionary medical treatment typically represents an investor's ideal scenario. However,...